Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on March 12, 2009

Arteriosclerosis, Thrombosis, and Vascular Biology. 2009
Published online before print March 12, 2009, doi: 10.1161/ATVBAHA.108.183442
A more recent version of this article appeared on June 1, 2009
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Correction (v29,pe131)
Right arrow All Versions of this Article:
29/6/843    most recent
ATVBAHA.108.183442v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilhelm, A. J.
Right arrow Articles by Sorci-Thomas, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilhelm, A. J.
Right arrow Articles by Sorci-Thomas, M. G.

Submitted on May 12, 2008
Accepted on February 27, 2009

Apolipoprotein A-I and its Role in Lymphocyte Cholesterol Homeostasis and Autoimmunity

Ashley J. Wilhelm ; Manal Zabalawi ; Jason M. Grayson ; Ashley E. Weant ; Amy S. Major ; John Owen ; Manish Bharadwaj ; Rosemary Walzem ; Lawrence Chan ; Kazuhiro Oka ; Michael J. Thomas ; and Mary G. Sorci-Thomas *

From the Departments of Pathology, Lipid Sciences Research Center (A.J.W., M.Z., M.B.M.G.S.-T.), Microbiology and Immunology (J.M.G., A.E.W.), and Biochemistry (J.O., M.J.T., M.G.S.-T.), Wake Forest University School of Medicine, Winston-Salem, NC; the Division of Cardiovascular Medicine, Department of Medicine (A.S.M.), Vanderbilt University School of Medicine, Nashville, Tenn; the Poultry Science Department (R.W.), Texas A&M University, College Station; and the Departments of Medicine and Molecular & Cellular Biology (L.C., K.O.), Baylor College of Medicine, Houston, Tex.

* To whom correspondence should be addressed. E-mail: msthomas{at}wfubmc.edu.

Objective—The purpose of this study was to determine the effects of an atherogenic diet on immune function in LDLr-/-, ApoA-I-/- mice.

Methods and Results—When LDLr-/-, ApoA-I-/- (DKO), and LDLr-/- (SKO) mice were fed an atherogenic diet, DKO had larger peripheral lymph nodes (LNs) and spleens compared to SKO mice. LNs were enriched in cholesterol and contain expanded populations of T, B, dendritic cells, and macrophages. Expansion of all classes of LN cells was accompanied by a {approx}1.5-fold increase in T cell proliferation and activation. Plasma antibodies to dsDNA, {beta}2-glycoprotein I, and oxidized LDL were increased in DKO, similar to levels in diet-fed Faslpr/lpr mice, suggesting the development of an autoimmune phenotype. Both LN enlargement and cellular cholesterol expansion were "prevented" when diet-fed DKO mice were treated with helper dependent adenovirus expressing apoA-I. Independent of the amount of dietary cholesterol, DKO mice consistently showed lower plasma cholesterol than SKO mice, yet greater aortic cholesterol deposition and inflammation.

Conclusions—ApoA-I prevented cholesterol-associated lymphocyte activation and proliferation in peripheral LN of diet-fed DKO mice. A {approx}1.5-fold increase in T cell activation and proliferation was associated with a {approx}3-fold increase in concentrations of circulating autoantibodies and {approx}2-fold increase in the severity of atherosclerosis suggesting a common link between plasma apoA-I, inflammation, and atherosclerosis.


Key words: ApoA-I • cholesterol • lymphocytes • lymph node • atherosclerosis